Clinical Trial Update: The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-Cholesterol [Phase 3]

View source ↗

Summary

Phase 3 HIT trial update for secondary prevention of coronary heart disease in men with low HDL and desirable LDL has completed. No efficacy results are provide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease

Snippet

Sponsor: VA Office of Research and Development | Conditions: Coronary Heart Disease | Phase 3 | Status: COMPLETED